Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Co-flumactone (Hydroflumethiazide/spironolactone)
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Co-flumactone 50mg/50mg tablets
0202040G0AAABAB
|
Co-flumactone | Co-flumactone (Hydroflumethiazide/spironolactone) | Cardiovascular System | 16 |
|
Aldactide 25 tablets
0202040G0BBAAAA
|
Aldactide | Co-flumactone (Hydroflumethiazide/spironolactone) | Cardiovascular System | 15 |
|
Aldactide 50 tablets
0202040G0BBABAB
|
Aldactide | Co-flumactone (Hydroflumethiazide/spironolactone) | Cardiovascular System | 15 |
|
Co-flumactone 25mg/25mg tablets
0202040G0AAAAAA
|
Co-flumactone | Co-flumactone (Hydroflumethiazide/spironolactone) | Cardiovascular System | 10 |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.